Update to previous notice regarding Proton Pump Inhibitors (PPI) coverage
We previously notified you that new users of the Proton Pump Inhibitors (PPIs) would be required to try two preferred products before a non-preferred product drug would be covered effective October 1, 2009. However, the PPI program requirement will remain unchanged. Users of nonpreferred PPIs (such as Prevacid, Zegerid) will continue to be required to try one of the preferred PPI options (omeprazole, pantoprazole, and Nexium) before the non-preferred drug will be covered. These drugs are most commonly used to treat acid reflux disease or heartburn.